CMC- Cipher Market Cap logo CMC- Cipher Market Cap logo
Shivom Crypto Coin Rank 1128
网站
911,746,999 OMX

Shivom
Shivom
OMX Coin Values OMX

Shivom valuesUSD 价钱
$ 0.0006

Shivom BTC 价钱
0.00000006

Shivom 24小时
$ 0

Shivom 市值
$ 517,674

24小时
0 BTC
1 H
0 %
24 H
0 %
7 d
0.14 %
今天 Shivom 目前以美元计价 0.0006 USD, 如果转换为 Bitcoin 0.00000006 BTC. 总计 911,746,999 OMX 目前正在市场上流传。 Shivom 价格目前正在经历变化 0 %, 校验 所有加密货币. 过去24小时 0.000 M US dollars Shivom 已被交易 加密交换. 得到 Shivom's 通过将其添加到您的 最爱 并创造一个免费的 投资组合.
全名
Shivom
符号
OMX
算法
BTC 价钱
0.00000006 BTC
BTC 市场
56 BTC
BTC 24h Vol
0 BTC
开采的总硬币
911,746,999 OMX
1h
0 %
24h
0 %
7d
0.14 %
Twitter
网站
Description

Shivom Crypto ICO Description

Shivom is a global blockchain-genomics ecosystem powering the next era of precision medicine. Shivom is building a genomic and health data hub by combining blockchain, genomic DNA sequencing, artificial intelligence and cryptography to power secure and personalized medicine.

Shivom works on principles of collaboration and integrity, allowing users to own, manage and monetize their genomics and health data. The Shivom team aims to reach even underserved and low-income countries where such services have not been previously available. This solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.

The platform users will be able to get their genome sequenced and securely stored, and the ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. Shivom has already partnered with the top developers and healthcare organizations.Technology companies and big pharma are already lining up to take advantage of the platform genomics and healthcare approach.

The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.

技术

Shivom Crypto Technology

Sorry, detailed technology about Shivom is not currently available

特征

Shivom Crypto Features

Sorry, detailed features about Shivom is not currently available

ICO Status

Shivom ICO Details

ICO 状态
Upcoming
令牌供应
3000000000
开始日期
2018-04-16
结束日期
2018-05-16
募集资金 (BTC)
N/A
募集资金 (USD)
N/A
开始价格 (USD)
0.00014
安全审计公司
Hosho Group
ICO法律表格
N/A
ICO管辖权
IOM
法律顾问
Greenberg Traurig

Shivom is a global blockchain-genomics ecosystem powering the next era of precision medicine. Shivom is building a genomic and health data hub by combining blockchain, genomic DNA sequencing, artificial intelligence and cryptography to power secure and personalized medicine.

Shivom works on principles of collaboration and integrity, allowing users to own, manage and monetize their genomics and health data. The Shivom team aims to reach even underserved and low-income countries where such services have not been previously available. This solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.

Team:

  • Dr. Axel Schumacher: Co-Founder & CEO.
  • Gourish Singla: Co-Founder & COO.
  • Sally Eaves: Co-Founder & CMO.
  • Per Lind: Co-Founder & CSO.
  • Henry Ines: Chief Innovation Officer.
  • Akash Gaurav: Co-Founder & CTO.

Shivom will be holding its ICO on the 16th of April, 2018. The ICO token supply represents 33% of the total token supply, so there will be a total of 990,000,000 tokens available, for 0.00014 ETH each during the offering. The ICO funding target is 15,000 ETH, the funding cap is 75,000 ETH and is expected to end on the 16th of May, 2018 or when the funding cap is reached. Any unsold/remaining tokens will be burned.

Token Reserve Split (67%):

  • 20% Pool;
  • 20% Reserve;
  • 14% Founders;
  • 10% Advisors;
  • 3% Community;

Shivom ICO will feature a bonus program and a bounty campaign, and the token will not be mineable.


获取加密通讯
阅读免责声明 : 此处提供的所有内容我们的网站,超链接网站,相关应用程序,论坛,博客,社交媒体帐户和其他平台(“网站”)仅供您提供一般信息,从第三方采购。 我们不对与我们的内容有任何形式的保证,包括但不限于准确性和更新性。 我们提供的内容中没有任何内容构成财务建议,法律建议或任何其他形式的建议,以满足您对任何目的的特定依赖。 任何使用或依赖我们的内容完全由您自行承担风险和自由裁量权。 在依赖它们之前,您应该进行自己的研究,审查,分析和验证我们的内容。 交易是一项高风险的活动,可能导致重大损失,因此请在做出任何决定之前咨询您的财务顾问。 我们网站上的任何内容均不构成招揽或要约